Patents by Inventor Ravindra Dnyandev Jadhav

Ravindra Dnyandev Jadhav has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Diacylglycerol acyltransferase inhibitors
    Patent number: 8835428
    Abstract: The present invention relates to isoxazole, thiazole and oxidiazole derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments, in particular to the use of these compounds in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1.
    Type: Grant
    Filed: February 24, 2011
    Date of Patent: September 16, 2014
    Assignee: Piramal Enterprises Limited
    Inventors: Ashok Kumar Gangopadhyay, Kishorkumar Shivajirao Kadam, Ravindra Dnyandev Jadhav, Hitesh Mistry, Rajiv Sharma
  • Inhibitors of diacylglycerol acyl transferase
    Patent number: 8748426
    Abstract: The present invention relates to heterocyclic compounds in all their stereoisomeric and tautomeric forms; and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutically acceptable polymorphs. The invention also relates to processes for the manufacture of the heterocyclic compounds and to pharmaceutical compositions containing them. The compounds and their pharmaceutical compositions are useful in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1. The present invention further provides a method of treatment of such diseases or disorders by administering a therapeutically effective amount of the compounds or their pharmaceutical compositions, to a mammal in need thereof.
    Type: Grant
    Filed: December 30, 2010
    Date of Patent: June 10, 2014
    Assignee: Piramal Enterprises Limited
    Inventors: Ravindra Dnyandev Jadhav, Rajiv Sharma
  • Carboxy oxazole or thiazole compounds as DGAT-1 inhibitors useful for the treatment of obesity
    Patent number: 8722901
    Abstract: Heteroaryl compounds, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or disorders mediated by Diacylglycerol acyltransferase (DGAT) enzyme, particularly DGAT-1 is described.
    Type: Grant
    Filed: November 1, 2010
    Date of Patent: May 13, 2014
    Assignee: Piramal Enterprises Limited
    Inventors: Ravindra Dnyandev Jadhav, Rajiv Sharma, Kishorkumar Shivajirao Kadam, Shivaji Sadashiv Kandre
  • HETEROCYCLIC COMPOUNDS AS DGAT1 INHIBITORS
    Publication number: 20130158075
    Abstract: The present invention relates to heterocyclic compounds of formula 1, in all their stereoisomeric and tautomeric forms; and their pharmaceutically acceptable salts, solvates, polymorphs, prodrugs, carboxylic acid isosteres and N-oxides. The invention also relates to processes for the manufacture of the heterocyclic compounds and to pharmaceutical compositions containing them. The said compounds and their pharmaceutical compositions are useful in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1. The present invention further provides a method of treatment of such diseases or disorders by administering a therapeutically effective amount of said compounds or their pharmaceutical compositions, to a mammal in need thereof.
    Type: Application
    Filed: August 31, 2011
    Publication date: June 20, 2013
    Applicant: PIRAMAL ENTERPRISES LIMITED
    Inventors: Rajiv Sharma, Kishorkumar Shivajirao Kadam, Ravindra Dnyandev Jadhav, Shivaji Sadashiv Kandre, Amol Gupte
  • INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE
    Publication number: 20120289505
    Abstract: The present invention relates to heterocyclic compounds in all their stereoisomeric and tautomeric forms; and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutically acceptable polymorphs. The invention also relates to processes for the manufacture of the heterocyclic compounds and to pharmaceutical compositions containing them. The said compounds and their pharmaceutical compositions are useful in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1. The present invention further provides a method of treatment of such diseases or disorders by administering a therapeutically effective amount of said compounds or their pharmaceutical compositions, to a mammal in need thereof.
    Type: Application
    Filed: December 30, 2010
    Publication date: November 15, 2012
    Inventors: Ravindra Dnyandev Jadhav, Rajiv Sharma
  • CARBOXY OXAZOLE OR THIAZOLE COMPOUNDS AS DGAT- 1 INHIBITORS USEFUL FOR THE TREATMENT OF OBESITY
    Publication number: 20120214854
    Abstract: Heteroaryl compounds, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or disorders mediated by Diacylglycerol acyltransferase (DGAT) enzyme, particularly DGAT-1 is described.
    Type: Application
    Filed: November 1, 2010
    Publication date: August 23, 2012
    Inventors: Ravindra Dnyandev Jadhav, Rajiv Sharma, Kishorkumar Shivajirao Kadam, Shivaji Sadashiv Kandre
  • DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS
    Publication number: 20110196002
    Abstract: The present invention relates to isoxazole, thiazole and oxidiazole derivatives, processes for their preparation, pharmaceutical compositions containing them and their use as medicaments, in particular to the use of these compounds in the prevention and treatment of diseases or disorders mediated by diacylglycerol acyltransferase (DGAT), particularly DGAT1.
    Type: Application
    Filed: February 24, 2011
    Publication date: August 11, 2011
    Inventors: Ashok Kumar GANGOPADHYAY, Kishorkumar Shivajirao Kadam, Ravindra Dnyandev Jadhav, Hitesh Mistry, Rajiv Sharma